3 completed, 1 terminated. 4 Phase 2, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 4 | Completed 3, Terminated 1 |
| Phase 1 | 1 | Terminated 1 |
Follow ASM-024: new trials by email Literature Review of ASM-024 trials Research Report on ASM-024
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Safety, Tolerability, and Clinical Activity of ASM-024 Administered to Patients With GOLD 2 or GOLD 3 Chronic Obstructive Pulmonary Disease (COPD) ASM-024, Placebo - COPD | Phase 2 | Completed | Asmacure Ltée | 14 | 2013-08-01 | 2014-12-16 |
| Safety, Tolerability and Pharmacokinetics of ASM-024 Administered to Healthy Subjects and Subjects With Moderate Asthma ASM-024 - Asthma | Phase 1 / Phase 2 | Terminated | Asmacure Ltée | 55 | 2013-03-01 | 2015-02-10 |
| Safety, Tolerability and Clinical Activity of ASM-024 in Stable Moderate Asthma ASM-024, ASM-024 100 mg, Placebo - Asthma | Phase 2 | Completed | Asmacure Ltée | 20 | 2010-08-01 | 2012-03-15 |
| Safety, Tolerability and Clinical Activity of ASM-024 in Subjects With Mild Allergic Asthma ASM-024, Placebo - Mild Allergic Asthma | Phase 2 | Completed | Asmacure Ltée | 24 | 2010-04-01 | 2012-01-26 |
Asthma (2) · Pulmonary Disease, Chronic Obstructive (1)
Asmacure Ltée (4)
Canada (4)
Yvon Cormier, M.D. (2) · Louis-Philippe Boulet, MD (1) · Richard Larouche, B. Pharm. MD (1)